Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1621 | XMD 8-92 trifluoroacetate | BMK1 inhibitor; ERK5 inhibitor | €70.00 | |
1846 | XMD 8-92 | BMK1 inhibitor; ERK5 inhibitor | €70.00 | |
1811 | VX 745 | Inhibitor of p38α MAP kinase | €90.00 | |
2520 | U 0126 | Non-competitive inhibitor of MEK1/2 and protects brain in stroke models | €90.00 | |
3282 | Takinib | Potent and selective TAK1 (MAP3K7) inhibitor | Recently added | €105.00 |
3183 | SR-318 | Highly potent and selective type-II p38 α/β inhibitor | €120.00 | |
2365 | SR 3576 | Very potent JNK3 inhibitor with >2800-fold selectivity over p38 | €135.00 | |
2519 | SP 600125 | Selective, reversible, and ATP-competitive JNK inhibitor | €70.00 | |
1122 | SL 327 | MEK1 and MEK2 inhibitor | €80.00 | |
2956 | Selonsertib | Potent, highly selective, orally available, and ATP-competitive ASK1 inhibitor | €90.00 | |
1357 | SD 169 | MAPK inhibitor (p38α specific) | €60.00 | |
1671 | SCIO 469 | MAPK inhibitor (p38 specific) | €110.00 | |
1897 | SB 747651A | Inhibitor of MSK1 | €120.00 | |
2444 | SB 706504 | Selective p38 MAPK inhibitor that targets a subset of inflammatory macrophage genes. | €125.00 | |
1465 | SB 203580 hydrochloride | MAPK inhibitor (p38 specific) | €70.00 |